azacitidine has been researched along with Cystic Fibrosis of Pancreas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abzianidze, E; Dabrundashvili, N; Gagua, M; Kamkamidze, M; Kvaratskhelia, E; Maisuradze, E | 1 |
Cheung, J; Furuta, T; Gruenert, DC; Kai, H; Li, JD; Oba, M; Okiyoneda, T; Shuto, T; Suico, MA; Uehara, A; Xu, H | 1 |
2 other study(ies) available for azacitidine and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
ALTERATION IN THE CYTOKINE SECRETION PATTERN IN T CELLS OF PATIENTS WITH CYSTIC FIBROSIS CAUSED BY DNA METHYLTRANSFERASE INHIBITOR 5-AZACITIDINE.
Topics: Adolescent; Azacitidine; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Cytokines; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Humans; T-Lymphocytes | 2017 |
Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells.
Topics: Azacitidine; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Methylation; Endoplasmic Reticulum; Epithelial Cells; Gene Expression Regulation; Humans; Inflammation; Peptidoglycan; Promoter Regions, Genetic; Respiratory Mucosa; Staphylococcus aureus; Toll-Like Receptor 2; Up-Regulation | 2006 |